Z.-Y. Lei et al. / Tetrahedron: Asymmetry 19 (2008) 2058–2062
2061
reaction with chiral phosphine-containing Lewis bases. Efforts are
in progress to elucidate the mechanistic details of this reaction and
to study its scope and limitations.
(br, 1H, OH), 4.84 (br, 1H, OH), 6.28 (d, J = 9.0 Hz, 1H, ArH), 6.72–
6.78 (m, 1H, ArH), 6.93–7.07 (m, 6H, ArH), 7.12–7.51 (m, 16H,
ArH), 7.78 (d, J = 8.1 Hz, 1H, ArH), 7.88–7.96 (m, 7H, ArH), 8.03 (t,
J = 8.7 Hz, 2H, ArH); 31P NMR (CDCl3, 121 MHz, 85% H3PO4) d
ꢁ10.03, ꢁ12.40; MS (EI) m/e 420.2 (M+, 58.95), 403.2 (M+ꢁ17,
100), 377.1 (M+ꢁ43, 80.13), 252.1 (M+ꢁ168, 25.60); HRMS (EI)
calcd for C29H25OP requires 420.1643, found: 420.1643.
4. Experimental
4.1. General remarks
4.5. (R)-1-(2-((Butyl(phenyl)phosphanyl)naphthalen-1-
yl)naphthalen-2-ol L5
1H NMR, 31P NMR and 13C NMR spectra were recorded on a Var-
ian Mercury vx-300 spectrometer for solution in DMSO or CDCl3
with tetramethylsilane (TMS) as an internal standard. Chiral HPLC
was performed on a SHIMADZU SPD-10A series with chiral col-
umns. Elementary analysis (CHN) was taken on a Carlo-Erba 1106
analyzer. Mass spectra were recorded by EI, and HRMS was mea-
sured on a HP-5989 instrument. Flash column chromatography
was performed using Silica Gel (300–400 mesh). Melting points
were uncorrected. All solvents were purified by distillation. Unless
otherwise noted, all commercially obtained reagents were used
without further purification. All reactions were carried out under
an argon atmosphere. Phosphane oxides were synthesized accord-
ing to literature procedures.5 Chiral phosphine-containing Lewis
bases catalysts L1–L6 were prepared by the methods previously
described.4,6 Products 3a–3i are known compounds.7 The absolute
configuration of MBH adducts 3 was determined by the sign of
specific rotations compared with the literature value.3b,d,f,7a,e
White solid; yield: 584 mg (67%); mp 68–70 °C; ½a D25
¼ ꢁ14:3 (c
ꢀ
0.83, CH2Cl2); IR (CH2Cl2)
m 3057, 2969, 1719, 1588, 1509, 1419,
1140, 940 cmꢁ1
; d 0.68 (t,
1H NMR (CDCl3, 300 MHz, TMS)
J = 6.9 Hz, 3H, CH3), 0.84 (t, J = 6.9 Hz, 3H, CH3), 1.11–1.15 (m, 4H,
CH2), 1.34–1.43 (m, 4H, CH2), 1.88 (t, J = 7.5 Hz, 2H, CH2), 2.04 (t,
J = 7.5 Hz, 2H, CH2), 4.54 (br, 1H, OH), 4.83 (br, 1H, OH), 6.54 (d,
J = 8.7 Hz, 1H, ArH), 6.87–7.06 (m, 7H, ArH), 7.15–7.38 (m, 14H,
ArH), 7.47–7.52 (m, 2H, ArH), 7.60–7.64 (m, 1H, ArH), 7.71–7.79
(m, 2H, ArH), 7.87–8.02 (m, 7H, ArH); 31P NMR (CDCl3, 121 MHz,
85% H3PO4) d ꢁ24.68; MS (EI) m/e 434.2 (M+, 53.07), 417.2
(M+ꢁ17, 100), 377.1 (M+ꢁ57, 25.42), 268.1 (M+ꢁ166, 53.69);
HRMS (EI) calcd for C30H27OP requires 434.1800, found: 434.1780.
4.6. (R)-1-(2-(Cyclohexyl(phenyl)phosphanyl)naphthalen-1-
yl)naphthalen-2-ol L6
White solid; yield: 560 mg (61%); mp 74–76 °C; ½a D25
¼ ꢁ18:8 (c
ꢀ
4.2. General procedure for the reduction of the phosphane
oxides
0.54, CH2Cl2); IR (CH2Cl2)
m 3055, 2926, 1708, 1619, 1596, 1513,
1433, 1144, 814 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS) d 0.92–
;
At 0 °C, HSiCl3 (8.0 mmol, 0.8 mL) was carefully added to a mix-
ture of phosphane oxide (2.0 mmol) and triethylamine (16 mmol,
2.1 mL) in toluene (50 mL) in a three-necked round-bottomed flask
under argon atmosphere. The reaction mixture was heated at
reflux for 16–24 h. After being cooled to room temperature, the
mixture was diluted with Et2O and quenched with small amount
of saturated NaHCO3. The resulting suspension was filtered
through Celite, and the solid was washed with Et2O. The combined
organic layers were dried over anhydrous MgSO4 and concentrated
under reduced pressure. The crude product was purified by flash
column chromatography (SiO2, EtOAc/petroleum ether, 1/10) to
give the product as a colourless solid (a pair of diastereoisomers).
1.43 (m, 8H, CH2), 1.51–1.78 (m, 12H, CH2), 2.25–2.44 (m, 2H,
CH), 4.24 (br, 1H, OH), 4.81 (br, 1H, OH), 6.31 (d, J = 8.7 Hz, 1H,
ArH), 6.74–6.79 (m, 1H, ArH), 6.95–6.97 (m, 5H, ArH), 7.03–7.53
(m, 17H, ArH), 7.76–8.05 (m, 10H, ArH); 31P NMR (CDCl3,
121 MHz, 85% H3PO4) d ꢁ15.35, ꢁ17.26; MS (EI) m/e 460.2 (M+,
85.00), 443.2 (M+ꢁ17, 100), 377.1 (M+ꢁ83, 89.54), 268.1
(M+ꢁ192, 55.87); HRMS (EI) calcd for C32H29OP requires
460.1956, found: 460.1956.
4.7. (R)-1-(2-(Isobutyl(phenyl)phosphanyl)naphthalen-1-
yl)naphthalen-2-ol L7
White solid; yield: 62%; mp 80.4–81.8 °C; ½a D25
¼ ꢁ14:8 (c 0.87,
ꢀ
4.3. (R)-1-(2-(Ethyl(phenyl)phosphano)naphthalen-1-
yl)naphthalen-2-ol L3
CH2Cl2); IR (CH2Cl2)
m 3054, 2952, 1727, 1616, 1590, 1461, 1434,
1335, 973 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS) d 0.55–0.60 (m,
;
6H), 0.92 (d, J = 6.6 Hz, 6H), 1.48–1.62 (m, 2H), 1.67–1.74 (m,
1H), 1.86–2.04 (m, 3H), 4.64 (br, 1H), 4.79 (br, 1H), 6.61 (d,
J = 8.7 Hz, 1H), 6.91–6.97 (m, 2H), 7.01–7.09 (m, 5H), 7.17–7.39
(m, 14H), 7.46–7.54 (m, 3H), 7.65–7.69 (m, 1H), 7.79 (d,
J = 8.4 Hz, 1H), 7.87–7.98 (m, 7H); 31P NMR (CDCl3, 121 MHz, 85%
H3PO4) d ꢁ27.87, ꢁ28.45; MS (EI) m/e 434.2 (M+, 59.58), 417.2
(M+ꢁ17, 72.80), 377.1 (M+ꢁ57, 48.28), 299.1 (M+ꢁ135, 18.99),
268.1 (M+ꢁ166, 100); HRMS (EI) calcd for C30H27OP requires
434.1800, found: 434.1802.
White solid; yield: 520 mg (64%); mp 168–170 °C; ½a D25
¼ ꢁ16:4
ꢀ
(c 0.93, CH2Cl2); IR (CH2Cl2)
m 3054, 2927, 1708, 1621, 1595, 1514,
1434, 1144, 815 cmꢁ1; 1H NMR (CDCl3, 300 MHz, TMS) d 0.79–0.89
(m, 3H, CH3), 1.01 (dt, J = 7.2 Hz, 17.4 Hz, 3H, CH3), 1.92 (q,
J = 7.5 Hz, 2H, CH2), 2.06 (q, J = 7.2 Hz, 2H, CH2), 4.50 (br, 1H,
OH), 4.84 (br, 1H, OH), 6.54 (d, J = 8.4 Hz, 1H, ArH), 6.86–7.05 (m,
7H, ArH), 7.14–7.38 (m, 14H, ArH), 7.46–7.51 (m, 2H, ArH), 7.64–
7.78 (m, 3H, ArH), 7.86–8.01 (m, 7H, ArH); 31P NMR (CDCl3,
121 MHz, 85% H3PO4) d ꢁ20.41, ꢁ20.83; MS (EI) m/e 406.1 (M+,
40.59), 405.1 (M+ꢁ1, 26.48), 390.2 (M+ꢁ16, 25.11), 389.1
(M+ꢁ17, 100), 252.1 (M+ꢁ154, 13.55); HRMS (EI) calcd for
4.8. (R)-1-(2-(Butyl(phenyl)phosphanyl)-5,6,7,8-tetra-
hydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol L8
C
28H23OP requires 406.1487, found: 406.1487.
White solid; yield: 69%; mp 104.5–106.0 °C; ½a D25
¼ þ5:0 (c
ꢀ
4.4. (R)-1-(2-(Isopropyl(phenyl)phosphanyl)naphthalen-1-
yl)naphthalen-2-ol L4
0.62, CH2Cl2); IR (CH2Cl2)
m 3047, 2929, 2857, 1730, 1591, 1475,
1434, 1276 cmꢁ1 1H NMR (CDCl3, 300 MHz, TMS) d 0.79–0.86
;
(m, 6H), 1.55–1.82 (m, 19H), 1.87–1.96 (m, 6H), 2.01–2.39 (m,
8H), 2.54–2.70 (m, 3H), 2.75–2.88 (m, 8H), 3.65 (br, 1H), 4.38 (br,
1H), 6.56 (d, J = 8.1 Hz, 1H), 6.82 (d, J = 8.1 Hz, 1H), 6.98–7.03 (m,
2H), 7.14–7.26 (m, 12H), 7.32–7.36 (m, 2H); 31P NMR (CDCl3,
121 MHz, 85% H3PO4) d ꢁ26.03, ꢁ26.87; MS (EI) m/e 442.2 (M+,
White solid; yield: 486 mg (58%); mp 149–150 °C; ½a D25
¼ ꢁ13:0
ꢀ
(c 0.58, CH2Cl2); IR (CH2Cl2)
m 3055, 2944, 1714, 1621, 1595, 1515,
1434, 1144, 815 cmꢁ1; 1H NMR (CDCl3, 300 MHz, TMS) d 0.83–0.99
(m, 8H, CH3), 1.12–1.19 (m, 4H, CH3), 2.58–2.66 (m, 2H, CH), 4.25